We Offer Worldwide Shipping
Login Wishlist

Bis(4-hydroxy-3-methylphenyl) sulfide

$92

  • Brand : BIOFRON

  • Catalogue Number : BN-O1089

  • Specification : 98%(HPLC)

  • CAS number : 24197-34-0

  • Formula : C14H14O2S

  • Molecular Weight : 246.33

  • PUBCHEM ID : 618879

  • Volume : 5mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BN-O1089

Analysis Method

Specification

98%(HPLC)

Storage

2-8°C

Molecular Weight

246.33

Appearance

Botanical Source

Structure Type

Category

SMILES

CC1=C(C=CC(=C1)SC2=CC(=C(C=C2)O)C)O

Synonyms

4,4'-Thiodi(o-cresol)/Phenol, 4,4'-thiobis[2-methyl-/4,4'-Sulfanediylbis(2-methylphenol)/4,4'-dihydroxy-3,3'-dimethyldiphenyl sulfide/4,4'-Thiobis(2-methylphenol)/Bis(4-hydroxy-3-methylphenyl) Sulfide/2,2'-dimethyl-4,4'-sulfanediyl-di-phenol/3,3'-dimethyl-4,4'-dihydroxydiphenyl sulfide/2,2'-Dimethyl-4,4'-sulfandiyl-di-phenol

IUPAC Name

4-(4-hydroxy-3-methylphenyl)sulfanyl-2-methylphenol

Density

1.3±0.1 g/cm3

Solubility

Flash Point

218.6±27.4 °C

Boiling Point

450.6±45.0 °C at 760 mmHg

Melting Point

123ºC

InChl

InChl Key

IBNFPRMKLZDANU-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:24197-34-0) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

28346141

Abstract

The anamniote lateral line system, comprising mechanosensory neuromasts and electrosensory ampullary organs, is a useful model for investigating the developmental and evolutionary diversification of different organs and cell types. Zebrafish neuromast development is increasingly well understood, but neither zebrafish nor Xenopus is electroreceptive and our molecular understanding of ampullary organ development is rudimentary. We have used RNA-seq to generate a lateral line-enriched gene-set from late-larval paddlefish (Polyodon spathula). Validation of a subset reveals expression in developing ampullary organs of transcription factor genes critical for hair cell development, and genes essential for glutamate release at hair cell ribbon synapses, suggesting close developmental, physiological and evolutionary links between non-teleost electroreceptors and hair cells. We identify an ampullary organ-specific proneural transcription factor, and candidates for the voltage-sensing L-type Cav channel and rectifying Kv channel predicted from skate (cartilaginous fish) ampullary organ electrophysiology. Overall, our results illuminate ampullary organ development, physiology and evolution.

DOI: http://dx.doi.org/10.7554/eLife.24197.001

Research Organism: Other

Title

Insights into electrosensory organ development, physiology and evolution from a lateral line-enriched transcriptome

Author

Melinda S Modrell,1 Mike Lyne,2,3 Adrian R Carr,2,3 Harold H Zakon,4,5 David Buckley,6,7 Alexander S Campbell,1 Marcus C Davis,8 Gos Micklem,2,3 and Clare VH Baker1,*

Publish date

2017;

PMID

25147453

Abstract

Two new species of Aphidura Hille Ris Lambers, 1956 (Hemiptera, Aphididae, Macrosiphini) are described; Aphidura libanensis sp. n. from Prunus prostrata in Lebanon, and Aphidura corsicensis sp. n. from Cerastium soleirolii in Corsica (France). Studies of Aphidura bozhkoae specimens from different localities have revealed that this species varies in its pattern of dorsal sclerotisation and other morphological characters, within and between populations. An updated key for identifying the world’s species of Aphidura is presented.

KEYWORDS

Aphidura, new taxa, descriptions, intraspecific variation, key of species

Title

Two more new species of Aphidura (Hemiptera, Aphididae), and a note on variation in Aphidura bozhkoae Narzikulov

Author

Juan M. Nieto Nafria,1 Roger L. Blackman,2 and Jon H. Martin2

Publish date

2014;

PMID

29603879

Abstract

Introduction
To close gaps in HIV prevention and care, knowledge about locations and populations most affected by HIV is essential. Here, we provide subnational and sub‐population estimates of three key HIV epidemiological indicators, which have been unavailable for most settings.

Methods
We used surveillance data on newly diagnosed HIV cases from 2004 to 2014 and back‐calculation modelling to estimate in France, at national and subnational levels, by exposure group and country of birth: the numbers of new HIV infections, the times to diagnosis, the numbers of undiagnosed HIV infections. The denominators used for rate calculations at national and subnational levels were based on population size (aged 18 to 64) estimates produced by the French National Institute of Statistics and Economic Studies and the latest national surveys on sexual behaviour and drug use.

Results
We estimated that, in 2014, national HIV incidence was 0.17‰ (95% confidence intervals (CI): 0.16 to 0.18) or 6607 (95% CI: 6057 to 7196) adults, undiagnosed HIV prevalence was 0.64‰ (95% CI: 0.57 to 0.70) or 24,197 (95% CI: 22,296 to 25,944) adults and median time to diagnosis over the 2011 to 2014 period was 3.3 years (interquartile range: 1.2 to 5.7). Three mainland regions, including the Paris region, out of the 27 French regions accounted for 56% of the total number of new and undiagnosed infections. Incidence and undiagnosed prevalence rates were 2‐ to 10‐fold higher than the national rates in three overseas regions and in the Paris region (p‐values < 0.001). Rates of incidence and undiagnosed prevalence were higher than the national rates for the following populations (p‐values < 0.001): born‐abroad men who have sex with men (MSM) (respectively, 108‐ and 78‐fold), French‐born MSM (62‐ and 44‐fold), born‐abroad persons who inject drugs (14‐ and 18‐fold), sub‐Saharan African‐born heterosexuals (women 15‐ and 15‐fold, men 11‐ and 13‐fold). Importantly, affected populations varied from one region to another, and in regions apparently less impacted by HIV, some populations could be as impacted as those living in most impacted regions. Conclusions In France, some regions and populations have been most impacted by HIV. Subnational and sub‐population estimates of key indicators are not only essential to adapt, design implement and evaluate tailored HIV interventions in France, but also elsewhere where similar heterogeneity is likely to exist.

KEYWORDS

HIV incidence, undiagnosed HIV prevalence, time to HIV diagnosis, subnational and sub‐population estimates, modelling, exposure group, geographical analysis, map

Title

Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France

Author

Lise Marty,corresponding author 1 Francoise Cazein, 2 Henri Panjo, 3 , 4 Josiane Pillonel, 2 Dominique Costagliola, 1 Virginie Supervie,corresponding author 1 and the HERMETIC Study Group †

Publish date

2018 Mar;


Description :

Empty ...